| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2020 | Nov 13, 2020 | Hofmeister Robert Chief Scientific Officer | Sell | Tcr2 Therapeutics Inc. | TCRR | $25.1 | $502,000 | -33.98% |
| Oct 29, 2020 | Nov 02, 2020 | Hofmeister Robert Chief Science Officer | Sell | Tcr2 Therapeutics Inc. | TCRR | $19.1 | $382,000 | -33.98% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.